BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29631126)

  • 1. Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites.
    Chua MJ; Robaa D; Skinner-Adams TS; Sippl W; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):189-193. PubMed ID: 29631126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
    Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
    ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
    Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
    Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
    Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
    Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
    Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing novel inhibitors against histone acetyltransferase (HAT: GCN5) of Plasmodium falciparum.
    Kumar A; Bhowmick K; Vikramdeo KS; Mondal N; Subbarao N; Dhar SK
    Eur J Med Chem; 2017 Sep; 138():26-37. PubMed ID: 28644986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.
    Vallone A; D'Alessandro S; Brogi S; Brindisi M; Chemi G; Alfano G; Lamponi S; Lee SG; Jez JM; Koolen KJM; Dechering KJ; Saponara S; Fusi F; Gorelli B; Taramelli D; Parapini S; Caldelari R; Campiani G; Gemma S; Butini S
    Eur J Med Chem; 2018 Apr; 150():698-718. PubMed ID: 29571157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.
    Verlinden BK; de Beer M; Pachaiyappan B; Besaans E; Andayi WA; Reader J; Niemand J; van Biljon R; Guy K; Egan T; Woster PM; Birkholtz LM
    Bioorg Med Chem; 2015 Aug; 23(16):5131-43. PubMed ID: 25684422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of antimalarial transmission blocking agents: Pharmacophore mapping of ligands active against stage-V mature gametocytes of
    Aher RB; Roy K
    J Biomol Struct Dyn; 2019 Sep; 37(14):3660-3673. PubMed ID: 30238847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.
    Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.
    Lee S; Lim D; Lee E; Lee N; Lee HG; Cechetto J; Liuzzi M; Freitas-Junior LH; Song JS; Bae MA; Oh S; Ayong L; Park SB
    J Med Chem; 2014 Sep; 57(17):7425-34. PubMed ID: 25137549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
    Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes.
    Lucantoni L; Fidock DA; Avery VM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2097-107. PubMed ID: 26787698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials.
    van der Watt ME; Reader J; Churchyard A; Nondaba SH; Lauterbach SB; Niemand J; Abayomi S; van Biljon RA; Connacher JI; van Wyk RDJ; Le Manach C; Paquet T; González Cabrera D; Brunschwig C; Theron A; Lozano-Arias S; Rodrigues JFI; Herreros E; Leroy D; Duffy J; Street LJ; Chibale K; Mancama D; Coetzer TL; Birkholtz LM
    J Antimicrob Chemother; 2018 May; 73(5):1279-1290. PubMed ID: 29420756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy.
    Fréville A; Cailliau-Maggio K; Pierrot C; Tellier G; Kalamou H; Lafitte S; Martoriati A; Pierce RJ; Bodart JF; Khalife J
    BMC Biol; 2013 Jul; 11():80. PubMed ID: 23837822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Asexual and Sexual Blood Stages of the Human Malaria Parasite P. falciparum with 7-Chloroquinoline-Based 1,2,3-Triazoles.
    Wadi I; Prasad D; Batra N; Srivastava K; Anvikar AR; Valecha N; Nath M
    ChemMedChem; 2019 Feb; 14(4):484-493. PubMed ID: 30609264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole Derivatives Are Potent against Multiple Life Cycle Stages of
    Leshabane M; Dziwornu GA; Coertzen D; Reader J; Moyo P; van der Watt M; Chisanga K; Nsanzubuhoro C; Ferger R; Erlank E; Venter N; Koekemoer L; Chibale K; Birkholtz LM
    ACS Infect Dis; 2021 Jul; 7(7):1945-1955. PubMed ID: 33673735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Dimethylisoxazole-Attached Imidazo[1,2-
    Muthengi A; Wimalasena VK; Yosief HO; Bikowitz MJ; Sigua LH; Wang T; Li D; Gaieb Z; Dhawan G; Liu S; Erickson J; Amaro RE; Schönbrunn E; Qi J; Zhang W
    J Med Chem; 2021 May; 64(9):5787-5801. PubMed ID: 33872011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in drug design strategies for bromodomain protein inhibitors to target
    Nguyen HHT; Yeoh LM; Chisholm SA; Duffy MF
    Expert Opin Drug Discov; 2020 Apr; 15(4):415-425. PubMed ID: 31870185
    [No Abstract]   [Full Text] [Related]  

  • 20. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials.
    Abraham M; Gagaring K; Martino ML; Vanaerschot M; Plouffe DM; Calla J; Godinez-Macias KP; Du AY; Wree M; Antonova-Koch Y; Eribez K; Luth MR; Ottilie S; Fidock DA; McNamara CW; Winzeler EA
    ACS Infect Dis; 2020 Apr; 6(4):613-628. PubMed ID: 32078764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.